Martin Daffertshafer, PhD, began his career at Evotec BioSystems GmbH in 1995, establishing the IT and Software Development Departments. He held various leadership roles at Evotec OAI AG and Evotec Technologies GmbH, including VP Drug Discovery Technologies. At Perkin Elmer, he advanced to global product manager for Software and later Portfolio Director Scientific Imaging Software. In 2019, he became global product manager for High Content Screening Software. Since 2023, he has been with Revvity. Martin holds a doctorate in physics from the University of Stuttgart, specializing in laser spectroscopic studies in organic thin films.